Johnson & Johnson Stock (NYSE:JNJ)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$249.97

52W Range

$162.78 - $269.43

50D Avg

$238.66

200D Avg

$222.92

Market Cap

$609.12B

Avg Vol (3M)

$8.24M

Beta

0.23

Div Yield

$5.24 (2.07%)

JNJ Company Profile


Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Show More

Industry

Drug Manufacturers - General

Sector

Healthcare

Exchange

NYSE

ADR

-

Country

US

Employees

141,700

IPO Date

Jan 02, 1962

Website

JNJ Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 25Dec 24Dec 23
Innovative Medicine$60.40B$56.96B-
MedTech$33.79B$31.86B$30.40B
INNOVATIVE MEDICINE--$54.76B

Fiscal year ends in Dec 25 | Currency in USD

JNJ Financial Summary


Dec 25Dec 24Dec 23
Revenue$94.19B$88.82B$85.16B
Operating Income$25.60B$22.15B$23.41B
Net Income$26.80B$14.07B$35.15B
EBITDA$32.58B$24.78B$23.32B
Basic EPS$11.03$5.84$13.88
Diluted EPS$11.03$5.79$13.72

Fiscal year ends in Dec 25 | Currency in USD

Latest Earnings Call Transcripts


Q2 26Jul 15, 26 | 8:30 AM
Q1 26Apr 14, 26 | 8:30 AM
Q4 25Jan 21, 26 | 8:30 AM

Peer Comparison


TickerCompany
AZNAstraZeneca PLC
NVSNovartis AG
NVONovo Nordisk A/S
GILDGilead Sciences, Inc.
UNHUnitedHealth Group Incorporated
ABBVAbbVie Inc.
MRKMerck & Co., Inc.
AMGNAmgen Inc.
PFEPfizer Inc.
SNYSanofi